Stroke Trial, Recruiting (NCT07129603)

Stroke Trial, Recruiting NCT07129603 Sponsor: Tamas Vegh, MD Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07129603 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who have had a non-traumatic subarachnoid haemorrhage (bleeding around the brain, not caused by injury) that has been identified through an angiography scan (a type of blood vessel imaging)
People whose treatment plan already includes a lumbar drain (a tube placed in the lower back) or a ventricular drain (a tube placed in the brain) to manage fluid

Who may not be able to join:

People whose subarachnoid haemorrhage was caused by a physical injury or trauma
People for whom neither the patient nor their legal representative has given consent to participate
People who had meningitis (an infection causing inflammation around the brain and spinal cord) within the 6 months before their bleeding event
People whose immune system is weakened, either due to a medical condition or medications that affect the number or function of white blood cells

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Csilla Molnár, MD PhD Full Professor, University of Debrecen, Faculty of Medicine, Department of Anaesthesiology and Intensive Care

Phone: +36302998097

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07129603

Sponsor: Tamas Vegh, MD

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +36302998097

More information: https://clinicaltrials.gov/study/NCT07129603

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who have had a non-traumatic subarachnoid haemorrhage (bleeding around the brain, not caused by injury) that has been identified through an angiography scan (a type of blood vessel imaging)
People whose treatment plan already includes a lumbar drain (a tube placed in the lower back) or a ventricular drain (a tube placed in the brain) to manage fluid

Who may not be able to join:

People whose subarachnoid haemorrhage was caused by a physical injury or trauma
People for whom neither the patient nor their legal representative has given consent to participate
People who had meningitis (an infection causing inflammation around the brain and spinal cord) within the 6 months before their bleeding event
People whose immune system is weakened, either due to a medical condition or medications that affect the number or function of white blood cells

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tamas Vegh, MD

Registry

ClinicalTrials.gov

Start date

1 August 2025

Est. completion

31 December 2029

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

DCI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov